-transparent.png){kind=logo}
Based on 5 years of cytogenetic evaluation in hematology, we report our observations on various hematologic proliferative disorders with ring chromosomes. Comparing our data to those previously published in the literature we analyzed the occurrence of the ring in relation to the age of onset, previous history of therapeutic or professional exposure to mutagenic agents, and mean survival. It is concluded that the presence of ring chromosomes may be linked to a poor prognosis.
Related Publications
C Werner-Favre, and
P Beris, and
D Piguet, and
E Engel
April 2015,
Translational pediatrics,
C Werner-Favre, and
P Beris, and
D Piguet, and
E Engel
September 1983,
Cancer genetics and cytogenetics,
C Werner-Favre, and
P Beris, and
D Piguet, and
E Engel
November 1975,
Experientia,
C Werner-Favre, and
P Beris, and
D Piguet, and
E Engel
April 1998,
Cancer genetics and cytogenetics,
C Werner-Favre, and
P Beris, and
D Piguet, and
E Engel
December 2018,
Anesthesiology clinics,
C Werner-Favre, and
P Beris, and
D Piguet, and
E Engel
January 1994,
Optometry clinics : the official publication of the Prentice Society,
C Werner-Favre, and
P Beris, and
D Piguet, and
E Engel
January 1986,
Vox sanguinis,
C Werner-Favre, and
P Beris, and
D Piguet, and
E Engel
January 1984,
Basic life sciences,
C Werner-Favre, and
P Beris, and
D Piguet, and
E Engel
February 1970,
Naika. Internal medicine,
C Werner-Favre, and
P Beris, and
D Piguet, and
E Engel
March 1964,
Geburtshilfe und Frauenheilkunde,
